NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in NeuroPace Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +17 vs. Q3 2023
- Shares held
- 12.7M
- +237.4K (+1.9%) vs. Q3 2023
- Total value
- $130.8M
- +$9.67M (+8.0%) vs. Q3 2023
- New holders
- 18
- 14 more added
- Sold out
- 1
- 8 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NPCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 112 | $422.4M |
| Q1 2026 | 113 | $347.9M |
| Q4 2025 | 100 | $405.9M |
| Q3 2025 | 80 | $267.5M |
| Q2 2025 | 99 | $250.7M |
| Q1 2025 | 90 | $294.1M |
| Q4 2024 | 62 | $233.5M |
| Q3 2024 | 48 | $103.1M |
| Q2 2024 | 51 | $109.1M |
| Q1 2024 | 54 | $176.4M |
| Q4 2023 | 41 | $130.8M |
| Q3 2023 | 25 | $175.9M |
| Q2 2023 | 22 | $78.6M |
| Q1 2023 | 24 | $82.0M |
| Q4 2022 | 24 | $25.9M |
| Q3 2022 | 28 | $68.1M |
| Q2 2022 | 32 | $91.2M |
| Q1 2022 | 40 | $149.5M |
| Q4 2021 | 41 | $181.5M |
| Q3 2021 | 39 | $177.4M |
| Q2 2021 | 44 | $259.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding NeuroPace Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,003,967 | $41.3M | 0.83% | −8,314−0.2% | Reduced |
| Morgan Stanley | 2,460,716 | $25.4M | 0.00% | +61,000+2.5% | Added |
| Soleus Capital Management, L.P. | 2,433,168 | $25.1M | 2.78% | −33,037−1.3% | Reduced |
| Nantahala Capital Management, LLC | 1,173,677 | $12.1M | 1.21% | −46,238−3.8% | Reduced |
| Kent Lake Capital LLC | 670,946 | $6.92M | 2.67% | +96,529+16.8% | Added |
| FMR LLC | 468,081 | $4.83M | 0.00% | −238,164−33.7% | Reduced |
| Vanguard Group Inc | 413,106 | $4.26M | 0.00% | +27,021+7.0% | Added |
| Millennium Management LLC | 172,403 | $1.78M | 0.00% | −11,766−6.4% | Reduced |
| Geode Capital Management, LLC | 115,996 | $1.20M | 0.00% | +5,787+5.3% | Added |
| Renaissance Technologies LLC | 108,325 | $1.12M | 0.00% | +64,040+144.6% | Added |
| BlackRock Inc. | 86,502 | $891.8K | 0.00% | +26,534+44.2% | Added |
| EAM Investors, LLC | 66,141 | $681.9K | 0.12% | −75,475−53.3% | Reduced |
| Susquehanna International Group, LLP | 42,285 | $436.0K | 0.00% | +42,285 | New |
| Jane Street Group, LLC | 36,822 | $379.6K | 0.00% | +36,822 | New |
| Northern Trust Corp | 35,022 | $361.1K | 0.00% | +12,821+57.7% | Added |
| Citigroup Inc | 35,021 | $361.1K | 0.00% | +32,037+1,073.6% | Added |
| Bridgeway Capital Management, LLC | 33,900 | $349.5K | 0.01% | −26,148−43.5% | Reduced |
| State Street Corp | 33,351 | $343.8K | 0.00% | +100+0.3% | Added |
| Bank of America Corp | 31,905 | $328.9K | 0.00% | +26,405+480.1% | Added |
| Balyasny Asset Management LLC | 27,156 | $280.0K | 0.00% | +27,156 | New |
| Qube Research & Technologies Ltd | 26,202 | $270.1K | 0.00% | +23,803+992.2% | Added |
| 683 Capital Management, LLC | 24,933 | $257.1K | 0.03% | +24,933 | New |
| Citadel Advisors LLC | 24,055 | $248.0K | 0.00% | +24,055 | New |
| Laurion Capital Management LP | 20,699 | $213.4K | 0.01% | +20,699 | New |
| ExodusPoint Capital Management, LP | 19,791 | $204.0K | 0.00% | +19,791 | New |
| Man Group plc | 19,298 | $199.0K | 0.00% | +19,298 | New |
| TownSquare Capital, LLC | 15,859 | $163.5K | 0.00% | +15,859 | New |
| Walleye Capital LLC | 14,320 | $147.6K | 0.00% | +14,320 | New |
| Marshall Wace, LLP | 14,171 | $146.1K | 0.00% | +14,171 | New |
| Barclays PLC | 13,971 | $144.0K | 0.00% | +3,132+28.9% | Added |
| Cubist Systematic Strategies, LLC | 11,415 | $117.7K | 0.00% | +11,415 | New |
| JPMorgan Chase & Co | 11,360 | $117.1K | 0.00% | +11,360 | New |
| Virtu Financial LLC | 10,764 | $111.0K | 0.01% | +10,764 | New |
| Financial Advocates Investment Management | 10,000 | $103.1K | 0.01% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 3,929 | $40.0K | 0.00% | +3,929 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 257 | $2.65K | 0.00% | +257 | New |
| Tower Research Capital LLC (TRC) | 252 | $2.60K | 0.00% | +252 | New |
| Advisor Group Holdings, Inc. | 233 | $2.40K | 0.00% | +233 | New |
| Federated Hermes, Inc. | 116 | $1.20K | 0.00% | −308−72.6% | Reduced |
| Royal Bank of Canada | 118 | $1.00K | 0.00% | +114+2,850.0% | Added |
| Wells Fargo & Company | 81 | $835 | 0.00% | +7+9.5% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| KCK Ltd. | – | – | – | – | Not filed |